Starting next year, the Korea Organization For Patient Group expressed regret to the MOHW and the HIRA, which triggered anxiety and confusion among cancer patients by announcing plans to exclude second-tier anticancer drugs from the coverage.

The Korea Organization For Patient Group urged the MOHW and the HIRA to give confidence in ensuring the continuity of treatment for patients taking anticancer drugs, which have been subject to new comprehensive applications. The Korea Organization For Patient Group released a press release on the 2nd and said, "The government and pharmaceutical companies should actively cooperate and ensure that all cancer patients receive health insurance benefits to quickly regis